LLY Stock Price, News and Analysis
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Market Cap: $1,059,906,000,343.48
Industry: PHARMACEUTICAL PREPARATIONS
Track LLY stock with real-time alerts and market analysis
Current Price: $1188.14
Eli Lilly and Company
LLY•United States
$1188.14
-2.53%$-30.86
Day Range
$1178.32-$1226.60
Volume
2.0M
Avg Volume
4.3K
Market News
3m@marketnews
Major market announcement affects tech stocks across all sectors
Was this helpful?
Earnings Report
July 11 at 8:21 PM@earnings
Earnings report shows significant growth in quarterly revenue
Was this helpful?
Regulatory Filing
July 10 at 8:21 PM@regulatory
Regulatory changes impact industry outlook for upcoming quarter
Was this helpful?